1-8 of 8
Uwe M. Martens
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Gemtuzumab Ozogamicin Plus Intensive Chemotherapy for Patients with NPM1 -Mutated Acute Myeloid Leukemia

Hartmut Döhner, Daniela Weber, Julia Krzykalla, Walter Fiedler, Michael W.M. Kühn, Thomas Schroeder, Karin Mayer, Michael Lübbert, Mohammad Wattad, Katharina Götze, Lars Fransecky, Elisabeth Koller, Gerald Wulf, Jan Schleicher, Mark Ringhoffer, Richard Greil, Bernd Hertenstein, Jürgen Krauter, Uwe M. Martens, David Nachbaur, Maisun Abu Samra, Sigrid Machherndl-Spandl, Nadezda Basara, Claudia Leis, Anika Schrade, Silke Kapp-Schwoerer, Lars Bullinger, Felicitas R. Thol, Michael Heuser, Peter Paschka, Verena I. Gaidzik, Maral Saadati, Axel Benner, Richard F. Schlenk, Konstanze Döhner, Arnold Ganser
Journal: Blood
Blood (2022) 140 (Supplement 1): 2010–2013.
https://doi.org/10.1182/blood-2022-166084
Published: 2022
Journal Articles

Elotuzumab in Combination with Lenalidomide, Bortezomib, Dexamethasone and Autologous Transplantation for Newly-Diagnosed Multiple Myeloma: Results from the Randomized Phase III GMMG-HD6 Trial

Hartmut Goldschmidt, Elias K Mai, Uta Bertsch, Britta Besemer, Mathias Haenel, Kaya Miah, Roland Fenk, Jana Schlenzka, Markus Munder, Jan Dürig, Igor Wolfgang Blau, Stefanie Huhn, Dirk Hose, Anna Jauch, Christina Kunz, Andreas Neubauer, Christof Scheid, Roland Schroers, Ivana v. Metzler, Aneta Schieferdecker, Joerg Thomalla, Peter Reimer, Rolf Mahlberg, Ullrich Graeven, Stephan Kremers, Uwe M. Martens, Christian Kunz, Manfred Hensel, Andrea Seidel-Glaetzer, Katja Weisel, Marc-Steffen Raab, Hans Salwender
Journal: Blood
Blood (2021) 138 (Supplement 1): 486.
https://doi.org/10.1182/blood-2021-147323
Published: 2021
Journal Articles

Treatment Results In Acute Myeloid Leukemia Over a Time Period Of 20 Years: Analysis Of The German-Austrian Acute Myeloid Leukemia Study Group (AMLSG)

Richard F. Schlenk, MD, Konstanze Döhner, MD, Michael Heuser, MD, Daniela Späth, MSc, Carina Morlok, Alexander Lamparter, Klaus-Henning Koehne, M.D., Heinz-August Horst, MD, Peter Brossart, MD, Gerhard Held, Andrea Kündgen, M.D., Mark Ringhoffer, MD, Mohammed Wattad, MD, Helmut R. Salih, MD, Katharina S. Goetze, MD, Gerald Wulf, MD, Matthias Theobald, MD, PhD, Mathias J. Rummel, MD, Walter Fiedler, MD, Jörg Westermann, MD, Hans Salwender, MD, Andreas L. Petzer, MD, Frank Hartmann, MD, Michael Lübbert, MD, Uwe M. Martens, MD, Richard Greil, MD, Hartmut Kirchner, MD, Peter Paschka, MD, Verena I. Gaidzik, MD, Sabine Kayser, MD, Veronica Teleanu, MD, Felicitas Thol, MD, Gudrun Göhring, MD, Arnold Ganser, MD, Hartmut Döhner, MD
Journal: Blood
Blood (2013) 122 (21): 3878.
https://doi.org/10.1182/blood.V122.21.3878.3878
Published: 2013
Journal Articles

Pharmacodynamic Analysis Of The Inhibitory Potency Of The Tyrosine Kinase Inhibitor Midostaurin In Combination With Intensive Chemotherapy Including Allogeneic Hematopoietic Stem Cell Transplantation Followed By Maintenance Therapy In FLT3 -ITD Positive Acute Myeloid Leukemia In The Ongoing AMLSG 16-10 Trial

Sabine Kayser, MD, Mark Levis, MD, PhD, Carina Morlok, Andrea Kuendgen, MD, Michael Heuser, MD, Walter Fiedler, MD, Joerg Westermann, MD, Katharina Goetze, MD, Helmut R. Salih, MD, Andreas L. Petzer, MD, Frank Hartmann, MD, Heinz A. Horst, MD, Uwe M. Martens, MD, Gerald Wulf, MD, Michael Luebbert, MD, Ph.D., Dominik Wolf, MD, Richard Greil, MD, Claus-Henning Koehne, MD, Mark Ringhoffer, MD, Hartmut Kirchner, MD, Michael Pfreundschuh, MD, Brigitte Schlegelberger, MD, PhD, Patricia Erdmann, Trivikram Rajkhowa, Peter Paschka, MD, Verena I. Gaidzik, MD, Veronica Teleanu, MD, Felicitas Thol, MD, Arnold Ganser, Hartmut Doehner, MD, Konstanze Doehner, MD, Richard F. Schlenk, MD
Journal: Blood
Blood (2013) 122 (21): 1283.
https://doi.org/10.1182/blood.V122.21.1283.1283
Published: 2013
Journal Articles

Azacitidine-Containing Induction Regimens Followed by Azacitidine Maintenance Therapy in High Risk Acute Myeloid Leukemia: First Results of the Randomized Phase-II AMLSG 12-09 Study (ClinicalTrials.gov No. NCT01180322)

Richard F Schlenk, MD, Wolfgang Herr, MD, Gerald Wulf, Helmut R Salih, MD, Jürgen Krauter, Prof. Dr. med., Hans Guenter Derigs, MD, Andrea Kündgen, Mark Ringhoffer, MD, Uwe M. Martens, MD, Bernd Hertenstein, Martin Griesshammer, MD, PhD, Michael Girschikofsky, MD, Helga Bernhard, MD, Jens Kersten, MD, Maria von Lilienfeld-Toal, MD, Elisabeth Koller, MD, Elisabeth Lange, MD, Jörg Westermann, MD, Daniela Späth, MSc, Gudrun Göhring, MD, Veronica Teleanu, MD, Axel Benner, Dipl.Stat., Konstanze Döhner, MD, Arnold Ganser, Hartmut Döhner, MD
Journal: Blood
Blood (2012) 120 (21): 412.
https://doi.org/10.1182/blood.V120.21.412.412
Published: 2012
Journal Articles

Telomere Elongation In Vivo and Clinical Response Upon Androgen Treatment in a Patient with Aplastic Anemia and a Heterozygous hTERT Gene Mutation,

Tim H Brümmendorf, Patrick Ziegler, PhD, Jamil Akkad, MD, Ute Brassat, PhD, Lucia Vankann, Jens Panse, MD, Stefan Wilop, MD, Stefan Balabanov, MD, PhD, Klaus Schwarz, MD, Uwe M. Martens, MD, PhD, Hubert Schrezenmeier, MD
Journal: Blood
Blood (2011) 118 (21): 3427.
https://doi.org/10.1182/blood.V118.21.3427.3427
Published: 2011
Journal Articles

Genome-wide analysis of DNA copy number changes and LOH in CLL using high-density SNP arrays

Dietmar Pfeifer, Milena Pantic, Ilona Skatulla, Justyna Rawluk, Clemens Kreutz, Uwe M. Martens, Paul Fisch, Jens Timmer, Hendrik Veelken
Journal: Blood
Blood (2006) 109 (3): 1202–1210.
https://doi.org/10.1182/blood-2006-07-034256
Published: 2006
Includes: Supplemental data
Journal Articles

Selective cytotoxicity and telomere damage in leukemia cells using the telomerase inhibitor BIBR1532

Hesham El-Daly, Miriam Kull, Stefan Zimmermann, Milena Pantic, Cornelius F. Waller, Uwe M. Martens
Journal: Blood
Blood (2005) 105 (4): 1742–1749.
https://doi.org/10.1182/blood-2003-12-4322
Published: 2005